Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Sales | 8,110 | 5,936 | 24,183 | 5,287 | 5,167 |
| Gross Profit | 8,110 | 5,936 | 24,183 | 5,287 | 5,167 |
| Operating Expenses | 23,561 | 20,462 | 20,453 | 20,407 | 13,534 |
| Operating Income | -15,451 | -14,526 | 3,730 | -15,120 | -8,368 |
| Other Income | 7,408 | -3,734 | 75 | 8,958 | -2,215 |
| Pre-tax Income | -8,043 | -18,261 | 3,805 | -6,162 | -10,583 |
| Income Tax | N/A | -309 | -1,789 | N/A | N/A |
| Net Income Continuous | -8,043 | -17,952 | 5,595 | -6,162 | -10,583 |
| Minority Interests | N/A | -2 | N/A | 86 | 1 |
| Net Income | $-8,043 | $-17,950 | $5,595 | $-6,248 | $-10,584 |
| EPS Basic Total Ops | -1.32 | -3.00 | 0.96 | -1.08 | -2.04 |
| EPS Basic Continuous Ops | -1.34 | -2.87 | 0.93 | -1.09 | -2.09 |
| EPS Diluted Total Ops | -1.32 | -2.88 | 0.84 | -1.08 | -2.16 |
| EPS Diluted Continuous Ops | -1.34 | -2.84 | 0.91 | -1.09 | -2.09 |
| EBITDA(a) | $-14,787 | $-13,893 | $4,316 | $-14,580 | $-7,859 |